Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06920745 · ClinicalTrials.gov registry record
TriClip CED RWE Study
A clinical trial of Tricuspid Regurgitation, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 2,200
- Enrollment target
- 1
- Study location
NCT06920745 is a study of Tricuspid Regurgitation that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 2,200 participants, above the 406-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (442% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06920745, a study of Tricuspid Regurgitation, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 2,200 participants
- Enrollment target
- 1
- Study location
Study Summary
This Coverage with Evidence Development (CED) study evaluates the long-term health outcomes of patients with symptomatic, severe or greater Tricuspid Regurgitation who received a Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) procedure using the TriClip system.
Conditions Studied
Interventions
- DEVICE The TriClip System
Study Locations (1)
California
- Abbott - Santa Clara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2025-07-08 |
| Est. Completion | 2032-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06920745
The ClinicalTrials.gov registry entry for NCT06920745 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 406-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (442% higher). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which The TriClip System is the first listed.
NCT06920745 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06920745 about?
NCT06920745 is a clinical study titled "TriClip CED RWE Study". This Coverage with Evidence Development (CED) study evaluates the long-term health outcomes of patients with symptomatic, severe or greater Tricuspid Regurgitation who received a Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) procedure using the TriClip system.
What is the current status of trial NCT06920745?
This trial is currently recruiting. The enrollment target is 2,200 participants. The study started on 2025-07-08. Estimated completion is 2032-07.
What conditions does trial NCT06920745 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation.
What interventions are being tested in trial NCT06920745?
The interventions under investigation include: The TriClip System (DEVICE).
Who is sponsoring clinical trial NCT06920745?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06920745 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
RECRUITING
-
TTVR Early Feasibility Study
RECRUITING · NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
RECRUITING · NA
-
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
RECRUITING · NA
-
TTVR STRONG Under Coverage With Evidence Development (CED) Study
RECRUITING
-
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.